PBH
Prestige Consumer Healthcare Inc.NYSEHealthcare$52.48-9.02%ClosedMarket Cap: $2.52B
As of 2026-04-06
Valuation
P/E (TTM)
13.53
PEG
—
P/B
1.44
P/S
2.40
EV/EBITDA
10.83
DCF Value
$233.39
FCF Yield
10.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
56.4%
Operating Margin
29.2%
Net Margin
16.9%
ROE
10.2%
ROA
5.3%
ROIC
6.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2026 | $283.4M | 55.5% | $82.5M | $46.7M | $0.97 | — |
| Q2 2026 | $274.1M | 56.2% | $79.7M | $42.2M | $0.86 | — |
| Q1 2026 | $249.5M | 54.2% | $71.8M | $47.5M | $0.95 | — |
| Q4 2025 | $296.8M | 59.2% | $88.4M | $50.1M | $1.00 | — |
| FY 2025 | $1.14B | 55.8% | $336.8M | $214.6M | $4.29 | — |
| Q3 2025 | $290.3M | 55.5% | $92.0M | $61.0M | $1.22 | — |
| Q2 2025 | $283.5M | 55.5% | $84.3M | $54.4M | $1.09 | — |
| Q1 2025 | $267.1M | 54.7% | $72.0M | $49.1M | $0.98 | — |
| Q4 2024 | $277.0M | 54.8% | $82.2M | $49.5M | $0.98 | — |
| FY 2024 | $1.13B | 55.5% | $342.4M | $209.3M | $4.17 | — |
| Q3 2024 | $282.7M | 55.9% | $86.8M | $53.0M | $1.06 | — |
| Q2 2024 | $286.3M | 55.9% | $88.3M | $53.6M | $1.07 | — |